Jonathan C. Cheng, Ph.D.
Affiliations: | 2003 | University of Southern California, Los Angeles, CA, United States |
Area:
DNA methylation, cancer, epigeneticsGoogle:
"Jonathan Cheng"Mean distance: 14248.8
Parents
Sign in to add mentor| Peter A. Jones | grad student | 2003 | USC | |
| (Characterization of zebularine: A novel inhibitor of DNA methylation with clinical potential.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Cheng JC, Chiang MT, Lee CH, et al. (2015) γ-Synuclein Expression Is a Malignant Index in Oral Squamous Cell Carcinoma. Journal of Dental Research |
| Gupta S, O'Donnell P, Plimack ER, et al. (2015) MP68-11 A PHASE 1B STUDY OF PEMBROLIZUMAB (PEMBRO; MK-3475) FOR ADVANCED UROTHELIAL CANCER Journal of Urology. 193 |
| Lai ZL, Tsou YA, Fan SR, et al. (2014) Methylation-associated gene silencing of RARB in areca carcinogens induced mouse oral squamous cell carcinoma. Biomed Research International. 2014: 378358 |
| Marquez VE, Kelley JA, Agbaria R, et al. (2005) Zebularine: a unique molecule for an epigenetically based strategy in cancer chemotherapy. Annals of the New York Academy of Sciences. 1058: 246-54 |
| Marquez VE, Barchi JJ, Kelley JA, et al. (2005) Zebularine: a unique molecule for an epigenetically based strategy in cancer chemotherapy. The magic of its chemistry and biology. Nucleosides, Nucleotides & Nucleic Acids. 24: 305-18 |
| Friedrich MG, Chandrasoma S, Siegmund KD, et al. (2005) Prognostic relevance of methylation markers in patients with non-muscle invasive bladder carcinoma. European Journal of Cancer (Oxford, England : 1990). 41: 2769-78 |
| Friedrich MG, Weisenberger DJ, Cheng JC, et al. (2004) Detection of methylated apoptosis-associated genes in urine sediments of bladder cancer patients. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 10: 7457-65 |
| Yoo CB, Cheng JC, Jones PA. (2004) Zebularine: a new drug for epigenetic therapy. Biochemical Society Transactions. 32: 910-2 |
| Cheng JC, Yoo CB, Weisenberger DJ, et al. (2004) Preferential response of cancer cells to zebularine. Cancer Cell. 6: 151-8 |
| Liang G, Lin JC, Wei V, et al. (2004) Distinct localization of histone H3 acetylation and H3-K4 methylation to the transcription start sites in the human genome. Proceedings of the National Academy of Sciences of the United States of America. 101: 7357-62 |